newsfilter
← Latest News
GlobeNewswire·

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

MIAMI, May 30, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress"), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders